The COVID-19 pandemic has forced businesses to work in different ways and re-evaluate their priorities. During difficult times, there is often an increased focus on cost efficiency and efforts are stepped up to eliminate wastage. The pandemic has also forced many businesses to accelerate their digital transformation plans in order to better support a fully remote workforce. While some businesses have struggled, there have been many cases where the pandemic has led to a massive increase in demand for products and services and they have had to quickly adapt.
During the COVID-19 pandemic, CloudHealth by VMware has been unable to attend trade shows and conferences to explain in-person how the CloudHealth platform can help businesses optimize and govern their cloud environments and achieve their objectives, at a time when the platform is needed the most.
The recent CloudLIVE conference, which was a 100% virtual event this year, demonstrated how digital tools can be harnessed to connect with the cloud community. Following on from that event, CloudHealth has announced it is running a series of 30-minute virtual group demos to introduce the CloudHealth platform and demonstrate the benefits. While in-person effects are preferred, these all-digital events are the next best thing, and are essential at a time when mass gatherings are not possible.
There is an added advantage of the group demos over in-person events. They let potential customers view the product and see the benefits in a totally no-pressure environment. The CloudHealth platform can be viewed, its features explored, questions can be asked, and attendees will discover how cloud management can be done differently.
The series of group demos kicks off on June 10, 2020 with an overview of the Cloud health platform. On June 17, 2020 there will be a deep dive to demonstrate how to improve security posture management through VMware Secure State.
There will be many more group demos scheduled over the coming weeks, with dedicated sessions in local languages and time zones in the UK, Germany, France, Italy, the Netherlands, Israel, the UAE, and in the Asia-pacific region.
